SOPHiA GENETICS S.A.
NASDAQ:SOPHMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $635.90M
- Beta
- 0.98
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.14
Volume 0.61M
Average 0.10M
SOPH EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
SOPHiA GENETICS S.A.NASDAQ: SOPH
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q1 FY2026 EPS (Basic) was -$0.27, compared with -$0.26 a year earlier. Trailing-twelve-month EPS (Basic) was -$1.18.
Context
- EPS (Basic) grew in size in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 2 analysts of -$0.95 (+18.6%) for the fiscal year ending Dec 2026, a step up from the -23.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.27+3.6% QoQ
- Last fiscal yearDec 2025
- -$1.17-23.2% YoY
- LTMMar 2026
- -$1.18-18.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -3.8% | +36.4% | +40.2 pp |
| 1 year | -23.2% | +18.6% | +41.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (1.17) USD
- Year-over-year change
- -23.2%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.17) | -23.2% |
| FY2024 | 2024-12-31 | (0.95) | +22.1% |
| FY2023 | 2023-12-31 | (1.22) | +10.3% |
| FY2022 | 2022-12-31 | (1.36) | -2.3% |
| FY2021 | 2021-12-31 | (1.33) | — |
EPS (Basic) vs competitors
How SOPH compares with its peers on the latest reported figures
- SOPH's LTM Mar 2026 EPS (Basic) of -$1.18 is the 8th highest of the 10 companies compared; the peer median is -$0.1.
- Its year-over-year change of -18.0% is the 7th highest of 10, against a peer median of +11.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
BLLNBillionToOne, Inc. | LTM Jun 2026 | $0.69 | +200.8% | — |
| LTM Mar 2026 | $0.67 | +5.7% | +16.1% | |
| LTM Mar 2026 | $0.41 | -60.4% | -25.9% | |
| LTM Mar 2026 | $0.37 | +143.4% | — | |
| LTM Mar 2026 | -$0.1 | -505.1% | — | |
| LTM Mar 2026 | -$1.02 | +20.9% | — | |
| LTM Sep 2026 | -$1.05 | +11.8% | — | |
| LTM Mar 2026 | -$1.18 | -18.0% | — | |
| LTM Mar 2026 | -$1.62 | +63.1% | — | |
| LTM Mar 2026 | -$3.72 | -223.5% | — | |
| Peer median (excluding SOPH) | -$0.1 | +11.8% | -4.9% | |
Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 40.45M | 47.56M | 62.37M | 65.17M | 77.27M |
| Cost of Revenue | 15.23M | 16.31M | 19.46M | 21.24M | 29.46M |
| Gross Profit | 25.22M | 31.25M | 42.91M | 43.94M | 47.81M |
| Gross Margin | 62.4% | 65.7% | 68.8% | 67.4% | 61.9% |
| Research & Development | 26.58M | 35.37M | 36.97M | 34.37M | 33.57M |
| Selling, General & Admin | 70.24M | 84.08M | 81.72M | 76.32M | 85.17M |
| Operating Expenses | 96.71M | 119.08M | 117.74M | 110.51M | 118.74M |
| Depreciation & Amortization | 3.61M | 5.57M | 8.34M | 8.6M | 9.53M |
| EBITDA | (69.24M) | (81.38M) | (69.57M) | (50.76M) | (64.4M) |
| EBITDA Margin | -171.2% | -171.1% | -111.5% | -77.9% | -83.3% |
| Operating Income | (71.49M) | (87.82M) | (74.83M) | (66.57M) | (70.93M) |
| Operating Margin | -176.7% | -184.7% | -120.0% | -102.1% | -91.8% |
| Interest Income | 20K | 1.32M | 4.55M | 3.36M | 1.87M |
| Interest Expense | 658K | 639K | 588K | 1.91M | 4.55M |
| Other Income / Expenses | (2.02M) | 238K | (3.67M) | 5.3M | (7.56M) |
| Income Before Tax | (73.51M) | (87.59M) | (78.5M) | (61.27M) | (78.49M) |
| Pre-Tax Margin | -181.7% | -184.2% | -125.9% | -94.0% | -101.6% |
| Income Tax Expense | 168K | (136K) | 486K | 1.22M | 512K |
| Net Income | (73.68M) | (87.45M) | (78.98M) | (62.49M) | (79M) |
| Net Margin | -182.1% | -183.9% | -126.6% | -95.9% | -102.2% |
| EPS (Basic) | (1.33) | (1.36) | (1.22) | (0.95) | (1.17) |
| EPS (Diluted) | (1.33) | (1.36) | (1.22) | (0.95) | (1.17) |
| Weighted Avg Shares | 55.3M | 64.1M | 64.75M | 65.78M | 67.54M |
| Weighted Avg Shares (Diluted) | 55.3M | 64.1M | 64.75M | 65.78M | 67.54M |
SOPHiA GENETICS S.A.
NASDAQ:SOPH
Intrinsic Alpha fair value
Locked
Current Price
$7.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.